Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$237,514,257
+$26,658,160 QoQ
Shares Held
1,848,360
+5.4% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#122
of 3,757 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. MRK ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
559,339 | $670,888,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,137,643 | $288,927,190 | |
| 3 | ABBV |
AbbVie Inc.
|
980,805 | $246,809,766 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
1,848,360 | $237,514,257 | |
| 5 | AMGN |
Amgen Inc
|
636,122 | $230,352,496 | |
| 6 | AZN |
Astrazeneca PLC
|
467,619 | $88,669,912 | |
| 7 | NVO |
Novo Nordisk A S
|
1,566,451 | $75,095,658 | |
| 8 | PFE |
Pfizer Inc
|
1,993,256 | $47,997,600 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,514,257 | 1,848,360 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $210,856,097 | 1,752,898 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $181,273,086 | 1,722,146 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $108,498,576 | 1,292,727 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $98,647,449 | 1,246,178 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $108,714,347 | 1,211,167 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $116,025,413 | 1,166,319 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $138,725,120 | 1,221,602 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $156,619,626 | 1,265,102 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $171,647,419 | 1,300,852 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $151,684,321 | 1,391,344 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $122,620,654 | 1,191,070 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $129,494,464 | 1,122,233 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $116,033,507 | 1,090,643 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $123,582,099 | 1,113,854 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $93,744,719 | 1,088,536 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $80,921,487 | 887,589 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $67,520,339 | 822,917 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $55,241,267 | 720,789 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $52,991,380 | 705,517 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $53,512,836 | 688,091 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $55,863,606 | 724,654 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $54,416,033 | 665,233 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $51,916,850 | 625,881 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $45,583,888 | 589,472 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $37,401,747 | 486,116 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||